Who owns MAIA?
Institutional ownership of MAIA Biotechnology Inc. from Form 13F, Q2 2026
36 institutional managers reported holding MAIA Biotechnology Inc. (MAIA) in Form 13F filings for Q2 2026, with 13,524,351 shares worth $19.4M. The largest reported holder was Solas Capital Management, LLC. Managers that filed both quarters added a net 372,113 shares (+2.8%). 13 opened new positions and 10 sold out.
- Funds holding
- 36
- Value held
- $19.4M
- New / sold out
- 13 / 10
- Net shares, same filers
- +2.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of MAIA
Share of 13F holdings is each fund's shares as a share of the 13,524,351 MAIA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Renaissance Technologies LLC New+$599K
- Vanguard Capital Management LLC Added+$488K
- BlackRock, Inc. Added+$396K
- Bleakley Financial Group, LLC New+$262K
- Geode Capital Management, LLC Added+$207K
- Vanguard Fiduciary Trust Co Added+$198K
- Morgan Stanley Added+$130K
- Northern Trust Corp Added+$105K
- State Street Corp Added+$90K
- Two Sigma Investments, LP New+$73K
Biggest sellers in Q2 2026
- Solas Capital Management, LLC Trimmed-$1.8M
- Cable Car Capital, LP Trimmed-$193K
- Corsair Capital Management, L.p. Sold out-$140K
- Creative Planning Sold out-$40K
- Ritholtz Wealth Management Sold out-$32K
- O'Shaughnessy Asset Management, LLC Sold out-$28K
- UBS Group AG Trimmed-$27K
- Catalyst Funds Management Pty Ltd Sold out-$15K
- Cambridge Investment Research Advisors, Inc. Sold out-$15K
- Curio Wealth, LLC Sold out-$3K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $2.9M and sold $2.3M; 9 added and 3 trimmed.
Schedule 13D and 13G filings on MAIA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15Solas Capital Management, LLC SCHEDULE 13G filed by MAIA Biotechnology Inc.Schedule 13G
Questions about MAIA ownership
- Who owns MAIA stock?
- 36 institutional investment managers reported MAIA positions in their Form 13F filings for Q2 2026, holding 13,524,351 shares worth $19.4M in total. Solas Capital Management, LLC reported the largest position.
- Are funds buying or selling MAIA?
- In Q2 2026, 13 managers opened new MAIA positions, 9 added, 3 trimmed and 10 sold out. Managers that filed in both quarters added a net 372,113 shares.
- How current is this MAIA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to MAIA by CUSIP. Options are left out. MAIA news and filings · MAIA insider trades · Top funds